| Product Code: ETC9523870 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Thrombosis Drugs Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Thrombosis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Thrombosis Drugs Market - Industry Life Cycle |
3.4 Suriname Thrombosis Drugs Market - Porter's Five Forces |
3.5 Suriname Thrombosis Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Thrombosis Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Suriname Thrombosis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of thrombotic disorders in Suriname |
4.2.2 Growing awareness among healthcare professionals and patients about thrombosis treatment options |
4.2.3 Advancements in research and development leading to the introduction of innovative thrombosis drugs |
4.3 Market Restraints |
4.3.1 High cost associated with thrombosis drugs leading to affordability issues for patients |
4.3.2 Limited access to healthcare facilities and specialized treatment in certain regions of Suriname |
4.3.3 Strict regulatory requirements and approval processes for new thrombosis drugs |
5 Suriname Thrombosis Drugs Market Trends |
6 Suriname Thrombosis Drugs Market, By Types |
6.1 Suriname Thrombosis Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Thrombosis Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Thrombosis Drugs Market Revenues & Volume, By Factor Xa Inhibitor, 2021- 2031F |
6.1.4 Suriname Thrombosis Drugs Market Revenues & Volume, By Low Molecular Weight Heparin, 2021- 2031F |
6.1.5 Suriname Thrombosis Drugs Market Revenues & Volume, By P2Y12 Platelet Inhibitor, 2021- 2031F |
6.1.6 Suriname Thrombosis Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Suriname Thrombosis Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Thrombosis Drugs Market Revenues & Volume, By Pulmonary Embolism, 2021- 2031F |
6.2.3 Suriname Thrombosis Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.2.4 Suriname Thrombosis Drugs Market Revenues & Volume, By Deep Vein Thrombosis, 2021- 2031F |
6.2.5 Suriname Thrombosis Drugs Market Revenues & Volume, By Other, 2021- 2031F |
7 Suriname Thrombosis Drugs Market Import-Export Trade Statistics |
7.1 Suriname Thrombosis Drugs Market Export to Major Countries |
7.2 Suriname Thrombosis Drugs Market Imports from Major Countries |
8 Suriname Thrombosis Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed thrombosis medication |
8.2 Number of thrombosis-related hospital admissions and readmissions |
8.3 Percentage of thrombosis patients achieving target therapeutic outcomes |
9 Suriname Thrombosis Drugs Market - Opportunity Assessment |
9.1 Suriname Thrombosis Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Thrombosis Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Suriname Thrombosis Drugs Market - Competitive Landscape |
10.1 Suriname Thrombosis Drugs Market Revenue Share, By Companies, 2024 |
10.2 Suriname Thrombosis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here